100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Samenvatting - Stofwisseling en hormonen 1 $16.46
Add to cart

Summary

Samenvatting - Stofwisseling en hormonen 1

 16 views  0 purchase
  • Course
  • Institution

Samenvatting van het vak "Stowisseling & Hormonen 1" gegeven door prof. De Block in de 2e Bachelor Geneeskunde aan de UA. Volledige samenvatting gebaseerd op slides én lesnotities. Bevat onder andere duidelijke overzichten van de hypothalamo-hypofysaire assen.

Preview 7 out of 113  pages

  • August 31, 2024
  • 113
  • 2023/2024
  • Summary
avatar-seller
Inhoudstafel
Fysiologie van de endocriene pancreas...................................................................................................... 6
Pancreas.............................................................................................................................................. 6
Eilandjes van Langerhans........................................................................................................ 6
Insuline................................................................................................................................................. 6
Biosynthese.............................................................................................................................. 6
Insulinesecretie.........................................................................................................................7
Werking van insuline (anabool hormoon)............................................................................... 10
Fysiologische werking van insuline........................................................................................ 12
Glucagon............................................................................................................................................ 13
Biosynthese............................................................................................................................ 13
Werking van glucagon............................................................................................................ 13
Fysio-biochemische werking van insuline en glucagon (samenvatting).............................................14
Somatostatine.................................................................................................................................... 14

Diabetes mellitus..........................................................................................................................................15
Diabetes mellitus................................................................................................................................ 15
Diagnose................................................................................................................................ 15
Type 1 diabetes mellitus.....................................................................................................................16
Subtypes.................................................................................................................................16
Pathogenese.......................................................................................................................... 16
Immuniteit............................................................................................................................... 18
Symptomatologie....................................................................................................................19
Type 2 diabetes mellitus.....................................................................................................................20
Pathogenese.......................................................................................................................... 20
Ominous Octet........................................................................................................................21
Diabetes risico inschatting......................................................................................................23
Type 1 vs. type 2................................................................................................................................ 23
Acute en chronische verwikkelingen.................................................................................................. 23
4 pathways van hyperglycemie-schade..................................................................................24
Hemoglobine A1C.................................................................................................................. 26
Metabole controle................................................................................................................... 27

Het hypothalamo-hypofysair systeem....................................................................................................... 28
Anatomie............................................................................................................................................ 28
Hypothalamus.........................................................................................................................28
Hypofyse.................................................................................................................................28
Fysiologie........................................................................................................................................... 30
Hypothalamo-hypofysaire relaties.......................................................................................... 30
Hypothalamische hormonen = hypofysiotrope hormonen...................................................... 31
Hormonen van de hypofyse....................................................................................................31
Hormonen van de neurohypofyse...................................................................................................... 32
Antidiuretisch hormoon (ADH) = arginine vasopressine (AVP).............................................. 32
Oxytocine................................................................................................................................34
Hormonen van de adenohypofyse..................................................................................................... 34
Pro-opiomelanocortine (POMC) processing...........................................................................34
Hypothalamo-hypofysaire-gonadale as..............................................................................................35

1

, Hypothalamo-hypofysaire-schildklier as.............................................................................................35
Hypothalamo-hypofysaire-bijnier as................................................................................................... 36
Hypothalamo-hypofysaire-mammaire as............................................................................................36
Pathologie: hyperprolactinemie.............................................................................................. 37
Hypothalamo-hypofysaire-groeihormoon as...................................................................................... 37
Somatostatine.................................................................................................................................... 38
Hypopituïtarisme................................................................................................................................ 38
Hypofysetumor = hypofysair adenoom................................................................................... 38

Fysiologie van het groeihormoon.............................................................................................................. 40
Synthese en secretie..........................................................................................................................40
Hypothalamo-hypofysaire-groeihormoon as...........................................................................40
Controle van GH-secretie....................................................................................................... 41
Werking van GH................................................................................................................................. 42
Fysiologische effecten............................................................................................................ 42
Pathologie.......................................................................................................................................... 43
GH-deficiëntie.........................................................................................................................43
GH-excess..............................................................................................................................43

Fysiologie van de hypothalame-hypofysaire gonadale as bij de man....................................................44
Anatomie............................................................................................................................................ 44
Hormonaal systeem........................................................................................................................... 45
GnRH en LH/FSH synthese................................................................................................... 45
Testes als eindorgaan.............................................................................................................46
Testosteron.........................................................................................................................................47
Biologische effecten van testosteron en dihydrotestosteron.................................................. 48

Fysiologie van de bijnier............................................................................................................................. 50
Morfologie...........................................................................................................................................50
Histologie................................................................................................................................50
Synthese van bijnierschorshormonen................................................................................................ 50
Synthese van cortisol............................................................................................................. 51
Synthese van aldosteron........................................................................................................ 52
Synthese van androgenen......................................................................................................52
Pathofysiologie....................................................................................................................... 52
Glucocorticoïden - cortisol..................................................................................................................53
Hypothalamo-hypofysaire-bijnier as....................................................................................... 53
Adrenocorticotroop hormoon (ACTH).....................................................................................54
Werking van glucocorticoïden................................................................................................ 54
Mineralocorticoïden - aldosteron........................................................................................................ 56
Controle van aldosteron......................................................................................................... 56
Werking van aldosteron.......................................................................................................... 56
Androgenen........................................................................................................................................56
Synthese van bijniermerghormonen...................................................................................................57
Biosynthese van catecholamines........................................................................................... 57
Werking van catecholamines..................................................................................................57
Metabolisatie van catecholamines..........................................................................................58
Pathofysiologie: hyperfunctie............................................................................................................. 58
2

, Primair aldosteronisme...........................................................................................................59
Hyperandrogenisme............................................................................................................... 59
Feochromocytoom..................................................................................................................59
Hypercorticisme: syndroom van Cushing............................................................................... 60
Pathofysiologie: insufficiëntie............................................................................................................. 61
Bijnierschorsinsufficiëntie....................................................................................................... 61

Fysiologie van de schildklier...................................................................................................................... 62
Anatomie en histologie....................................................................................................................... 62
Synthese van iodothyronines............................................................................................................. 62
Biosynthese van iodothyronines.............................................................................................62
Transport van iodothyronines................................................................................................. 64
Transformatie van iodothyronines.......................................................................................... 64
Schildklierwerking...............................................................................................................................65
Hypothalamo-hypofysaire-schildklier as................................................................................. 65
Metabole activiteit van schildklierhormonen........................................................................... 66
Schildklierfunctie testen......................................................................................................................67
Pathologie: hyperthyroïdie..................................................................................................................67
Graves-Basedow.................................................................................................................... 68
Toxisch adenoom....................................................................................................................68
Toxische multinodulaire goiter................................................................................................ 68
Jodium-geïnduceerde hyperthyroïdie..................................................................................... 69
Thyroïditis............................................................................................................................... 69
Kliniek van hyperthyroïdie...................................................................................................... 70
Pathologie: hypothyroïdie...................................................................................................................70
Etiologie..................................................................................................................................71
Hashimoto = chronisch autoimmune thyroïditis......................................................................71
Kliniek van hypothyroïdie........................................................................................................72

Fysiologie van de bijschildklier.................................................................................................................. 73
Anatomie en histologie....................................................................................................................... 73
Synthese van parathyroïdhormoon (PTH)..........................................................................................73
Controle van PTH................................................................................................................... 73
Werking van parathyroïdhormoon (PTH)........................................................................................... 75
Werking van PTH in nieren.....................................................................................................75
Werking van PTH in bot..........................................................................................................76
Werking van PTH in darmen.................................................................................................. 77
Calcium metabolisme......................................................................................................................... 77
Calcium homeostase.............................................................................................................. 78
Fosfaat homeostase............................................................................................................... 79
1,25-dihydroxy-vitamine D3....................................................................................................79
Calcitonine..............................................................................................................................80

Fysiologie van het lipidenmetabolisme..................................................................................................... 81
Lipiden................................................................................................................................................81
Cholesterolmetabolisme......................................................................................................... 81
Lipoproteïnen..................................................................................................................................... 83
Lipoproteïnen..........................................................................................................................83
3

, Apolipoproteïnen.................................................................................................................... 83
Exogene en endogene pathway.........................................................................................................84
Exogene cholesterolpathway..................................................................................................85
Endogene cholesterolpathway............................................................................................... 85
Regulatie van LPL.................................................................................................................. 86
Regulatie van LDL-receptor....................................................................................................86
Implicaties voor de kliniek.................................................................................................................. 87
Bepaling van bloedlipiden.......................................................................................................87
Hyperlipidemie........................................................................................................................88
Werkingsmechanismen van lipiden-verlagende medicatie................................................................ 89
Cholesterolverlagende medicatie........................................................................................... 89
Triglyceriden verlagende medicatie........................................................................................ 91
Effecten van lipidenverlagende medicatie.............................................................................. 92

Gewichtshomeostase.................................................................................................................................. 93
Lichaamssamenstelling en metabolisme............................................................................................93
Antropometrische metingen....................................................................................................93
Metabolisme........................................................................................................................... 94
Centraal zenuwstelsel........................................................................................................................ 94
Hypothalamus.........................................................................................................................94
Melanocortine systeem...........................................................................................................95
Autonoom (perifeer) zenuwstelsel......................................................................................................95
Communicatie tussen vetcellen en hersenen.....................................................................................95
Leptine....................................................................................................................................95
Adiponectine...........................................................................................................................96
Communicatie tussen gastro-intestinaal stelsel en hersenen............................................................ 97
Ghreline.................................................................................................................................. 97
Glucagon-like peptide-1 (GLP-1)............................................................................................98
Oxyntomoduline......................................................................................................................99
Communicatie tussen pancreas en hersenen.................................................................................... 99
Insuline................................................................................................................................... 99
Amyline.................................................................................................................................100
Communicatie tussen smaakpapillen en hersenen..........................................................................100
Communicatie tussen lever en hersenen......................................................................................... 100
FGF-21................................................................................................................................. 100
Communicatie binnen de hersenen..................................................................................................101
Circadiaans ritme..................................................................................................................101

Elementaire voedingsleer..........................................................................................................................102
Algemene voedingsaanbevelingen.................................................................................................. 102
Basaal metabolisme (BMR)..................................................................................................102
Physical activity level (PAL).................................................................................................. 102
Totale energiebehoefte (EN).................................................................................................103
Macronutriënten............................................................................................................................... 103
Koolhydraten........................................................................................................................ 103
Vetten................................................................................................................................... 104
Eiwitten................................................................................................................................. 106
Voedingsvezels................................................................................................................................ 107
4

,Zoetstoffen en lightproducten........................................................................................................... 107
Intensieve zoetstoffen...........................................................................................................107
Extensieve zoetstoffen......................................................................................................... 108
Zoetstoffen in frisdranken..................................................................................................... 108
Vitaminen......................................................................................................................................... 109
Vitamine B............................................................................................................................ 109
Vitamine C = ascorbinezuur..................................................................................................110
Vitamine A.............................................................................................................................111
Vitamine D.............................................................................................................................111
Vitamine E.............................................................................................................................112
Vitamine K.............................................................................................................................112
Voorlichtingsmodel: Actieve Voedingsdriehoek................................................................................ 113
Basis: lichaamsbeweging..................................................................................................... 113
7 noodzakelijke voedingsgroepen........................................................................................ 113
Restgroep............................................................................................................................. 114




5

,Fysiologie van de endocriene pancreas
Pancreas
● exocrien deel
○ secretie van spijsverteringsenzymen en HCO3- in de GI-tractus
● endocrien deel
○ eilandjes van Langerhans


Eilandjes van Langerhans
● +/- 1-1.5 miljoen eilandjes = 1-1.5% van de pancreasmassa
● elk eilandje bevat 2500 cellen, bestaande uit 4 types
○ 60-75% β-cellen: insuline en amyline
○ 20-25% α-cellen: glucagon
○ 4% δ-cellen: somatostatine
○ 2% PP-cellen = F-cellen: pancreatic polypeptide

communicatie
● humoraal: via bloedvoorziening (van centraal → perifeer)
○ hormonale secreties van cellen in het centrum
beïnvloeden hormonale vrijstelling van cellen in de
periferie
○ insuline (β-cellen) remt vrijstelling van glucagon (α-cellen)
● neuraal: OS en PS van het autonoom zenuwstelsel
○ cholinerge stimulatie van insuline
● cel-tot-cel
○ via gap junctions en tight junctions

distributie van cellen in eilandjes van Langerhans
● β-cellen: centraal
● de rest: perifeer

hormoondistributie in de pancreas
● insuline: gelijkmatige verdeling
● pancreatic polypeptide: vooral in processus uncinatus en hoofd
● glucagon: vooral in de staart

type 1 diabetes: afwezige insulineproductie
● invaliderende langetermijncomplicaties: oogaantasting, nierbelasting
● behandeling: β-cel transplantatie → β-cellen (van donoren) in v. portae inspuiten om
insulineproductie te normaliseren
○ nadeel: 5-6 pancreassen nodig voordat voldoende grote hoeveelheid β-cellen is verzameld +
slechts 2 weken op celcultuur bewaren


Insuline

Biosynthese
1. transcriptie van het gen op chromosoom 11 (DNA) resulteert in productie van mRNA dat codeert
voor pre-proinsuline

6

, 2. vorming van proinsuline door translatie thv het endoplasmatisch reticulum (ribosomen)
3. verpakking van proinsuline in secretoire granules thv het golgi-apparaat
4. splitsing van proinsuline door protease, waardoor C-peptide (connecting peptide) wordt afgesplitst
van de α- en β-keten die aan elkaar gebonden zijn door disulfidebruggen (insuline)
5. secretie van insuline in de portale circulatie, waarvan 60% wordt geëlimineerd door de lever tijdens
first pass effect
6. excretie van C-peptide door de nieren (niet geëlimineerd door de lever)




C-peptide
● gebruikt als merker voor endogene insulinesecretie
● bv. patiënt met familiale diabetes die behandeld wordt met
insuline
○ insuline-meting geeft ook het ingespoten insuline weer
○ endogene en exogene insuline onderscheiden dankzij
C-peptide
● type 1 diabetes: afwezig insulineproductie
○ geen C-peptide
● type 2 diabetes: relatief insulinetekort
○ aanwezig C-peptide

insuline: α-keten (21 AZ) en β-keten (30 AZ), verbonden door disulfidebruggen
● wijziging in AZ-sequentie en replacement van AZ → farmacokinetisch en farmacodynamisch profiel
wijzigen
● gevolg: ultra-traag vs. ultra-snelwerkende insulines


Insulinesecretie ⭐⭐⭐
maaltijd: insulineconcentratie stijgt door glucose, neurale en incretine-gemedieerde stimulatie van β-cellen

stimulatie: glucose
1. β-cel neemt glucose op via GLUT2-transporters (gefaciliteerde diffusie)
2. glucose wordt oiv glucokinase omgezet tot glucose-6-fosfaat, en ondergaat verdere glycolyse tot
pyruvaat
3. pyruvaat ondergaat oiv pyruvaat dehydrogenase de oxidatieve decarboxylatie in het mitochondriën,
met vorming van acetyl-CoA
4. acetyl-CoA wordt verder gemetaboliseerd in de krebscyclus met productie van ATP dankzij de
protonengradiënt en oxidatieve fosforylatie
5. toegenomen intracellulaire ATP-concentratie zorgt voor sluiten van KATP-gevoelige K+-kanalen
6. verminderde K+-geleiding veroorzaakt depolarisatie van het celmembraan
7. membraandepolarisatie opent de voltage-gated Ca2+-kanalen
8. verhoogde Ca2+-influx resulteert in toegenomen intracellulaire vrije Ca2+-concentratie
9. dit lokt een additionele Ca2+-geïnduceerde Ca2+-release uit thv het endoplasmatisch reticulum
10. exocytose en vrijstelling van insuline in 2 fases
● acute first-phase insuline response (FPIR): reeds gevormde en opgeslagen insuline
vrijstellen uit de secretoire granules
● second-phase insuline response: zowel reeds gesynthetiseerd als nieuw gevormd insuline
vrijstellen
7

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller katovandenbroucke. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $16.46. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

59063 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 15 years now

Start selling
$16.46
  • (0)
Add to cart
Added